| 2018 | 14-3-3 zeta Overexpression is Associated with Poor Prognosis in Ovarian Cancer | 김승철; 성순희; 조민선; 주웅; 김윤환 | Article |
| 2017 | Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer | 주웅; 안정혁; 성혜윤 | Article |
| 2022 | Adenosine derivatives from Cordyceps exert antitumor effects against ovarian cancer cells through ENT1-mediated transport, induction of AMPK signaling, and consequent autophagic cell death | 박윤정 | Article |
| 2020 | BRCA1/BRCA2 pathogenic variant breast cancer: Treatment and prevention strategies | 문병인 | Review |
| 2018 | Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer | 주웅; 안정혁 | Article |
| 2021 | Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation | 권영주 | Article |
| 2016 | Estimation of prognostic marker genes by public microarray data in patients with ovarian serous cystadenocarcinoma | 박현석 | Article |
| 2023 | Identification of a novel <i>PARP4</i> gene promoter CpG locus associated with cisplatin chemoresistance | 주웅; 안정혁; 성혜윤 | Article |
| 2016 | Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry | 김승철; 주웅; 김윤환 | Article |
| 2016 | Low-mass-ion discriminant equation (LOME) for ovarian cancer screening | 김승철; 김윤환 | Article |
| 2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | 김윤환 | Article; Proceedings Paper |
| 2019 | SPSB1 enhances ovarian cancer cell survival by destabilizing p21 | 김승철; 주웅; 안정혁; 성혜윤; 김윤환; 김현정; 김미경 | Article |
